DraftKings Hit With California Class-Action Over Prediction Markets
Plaintiffs allege DraftKings' prediction market product violates California gambling law in a potentially sector-defining case.
California plaintiffs filed a class-action lawsuit against DraftKings this week, alleging the company's prediction market product constitutes illegal gambling under state law, according to Card Player.
Why It Matters
California is the largest U.S. consumer market, and a successful class-action here could expose DraftKings to substantial financial liability while setting a precedent that chills prediction market expansion nationally. The core legal question — whether prediction markets are gambling instruments or financial contracts — remains unsettled across most U.S. jurisdictions. DraftKings' stock and its prediction market ambitions both carry elevated risk until courts or regulators draw a clear line. Players and bettors using prediction market products in California should treat participation as legally uncertain. Gambling always involves financial risk; regulatory risk compounds that here.
Context
Prediction markets have occupied a regulatory grey zone in the U.S. for years. The CFTC's jurisdiction over event contracts has been contested, and state gambling laws — particularly California's strict statutes — have never formally accommodated prediction market wagering. DraftKings entered the prediction market space as part of a broader industry push, alongside platforms such as Kalshi and Polymarket, to normalise event-contract trading for retail participants.
What's Next
The case will proceed through California's federal or state court system, with an early motion to dismiss likely testing whether the product meets the legal definition of gambling. A ruling in either direction as of late 2026 or 2027 would carry significant weight for the entire prediction market sector.
Related on WeeBet
Keep reading
WeeBet Weekly
The week's biggest market move, in 4 minutes.
Every Friday: the top Polymarket and Kalshi price shift, one regulatory story that actually matters, and one chart. No fluff, no promo. Free.
Free. Unsubscribe in one click. We'll never sell your email.